Author

N. Ivetic

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Biochemistry· 1 Immunology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Organism:human· 2 Research Focus:protein folding & dynamics· 2 Assay:proteomics· 2 Approach:statistical model· 2 Research Focus:cell type annotation· 1 Approach:deep learning· 1

Frequent Co-Authors

D. G. Ivanov· 2 shared I. A. Kaltashov· 2 shared I. Nazy· 2 shared S. N. Nguyen· 2 shared D. Favre· 1 shared H. S. Le· 1 shared S.-H. Le· 1 shared Y. Du· 1 shared

Activity by Year

2023-2023 · peak 2/yr

Co-Author Collaboration Network

8 top collaborators · 25 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersImmunology

D. G. Ivanov

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Reverse engineering of a pathogenic antibody reveals the molecular mechanism of vaccine-induced immune thrombotic thrombocytopenia

D. G. Ivanov, N. Ivetic, Y. Du, S. N. Nguyen, H. S. Le, D. Favre, I. Nazy, I. A. Kaltashov

This paper identifies a pathogenic antibody causing VITT, characterizes its structure and function, and reveals the molecular mechanism involving electrostatic interactions and immune complex formation.

bioRxiv · Jun 30, 2023Immunology

Structural characterization of a pathogenic antibody underlying vaccine-induced immune thrombotic thrombocytopenia (VITT)

S. N. Nguyen, S.-H. Le, D. G. Ivanov, N. Ivetic, I. Nazy, I. A. Kaltashov

This paper characterizes a pathogenic anti-PF4 antibody from VITT patients, revealing its monoclonal nature, N-glycosylation site, and subclass composition.

bioRxiv · May 28, 2023Biochemistry